Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center

New York, New York 10016

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Malignant Melanoma Clinical Trial
Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab
Status: Enrolling, Phase I
Updated: 4/5/2017
Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™
Status: Enrolling, Phase III
Updated: 12/31/1969
Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials